Home › Funds › PERCEPTIVE ADVISORS LLC › PTGX
PERCEPTIVE ADVISORS LLC position in PTGX
PROTAGONIST THERAPEUTICS INC · Health Care
PERCEPTIVE ADVISORS LLC reported holding 981,879 shares of PTGX (PROTAGONIST THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$120.4M, representing 1.91% of its reported portfolio and ranking #16 among its reported holdings. PERCEPTIVE ADVISORS LLC has disclosed PTGX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How PERCEPTIVE ADVISORS LLC's PTGX position evolved
PERCEPTIVE ADVISORS LLC first disclosed a stake in PTGX in Q3 2023 at 1,054,273 shares (US$17.6M). The position peaked in Q1 2026 at 1,230,879 shares, worth US$129.7M. Across 12 filings, PERCEPTIVE ADVISORS LLC increased the stake 4 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 981,879 shares valued at US$120.4M — a reduction of -249,000 shares quarter over quarter.. Notable position changes include a 64% trim in Q4 2023 (shares rose 26% over the following quarter), a 159% increase in Q1 2024 (shares rose 20% over the following quarter), a 31% increase in Q4 2025 (shares rose 21% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.05M | $17.59M | New |
| Q4 2023 | 383.26K | $8.79M | Reduce |
| Q1 2024 | 994.32K | $28.77M | Add |
| Q2 2024 | 1.27M | $43.96M | Add |
| Q3 2024 | 1.37M | $61.86M | Add |
| Q4 2024 | 1.27M | $49.09M | Reduce |
| Q1 2025 | 1.09M | $52.77M | Reduce |
| Q2 2025 | 1.07M | $59.38M | Reduce |
| Q3 2025 | 1.03M | $68.43M | Reduce |
| Q4 2025 | 1.35M | $117.95M | Add |
| Q1 2026 | 1.23M | $129.73M | Reduce |
| Q2 2026 | 981.88K | $120.36M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PTGX and 13F data
PTGX (PROTAGONIST THERAPEUTICS INC) is a Health Care company. 48 other funds we track also report a position in PTGX — the largest reported positions include Farallon Capital Management (US$778.2M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$778.2M), RTW INVESTMENTS, LP (US$620.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PTGX
- Farallon Capital Management 6.35M sh · $778.25M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 6.35M sh · $778.25M · Q2 2026
- RTW INVESTMENTS, LP 5.06M sh · $620.40M · Q2 2026
- JOHNSON & JOHNSON 2.45M sh · $300.22M · Q2 2026
- Woodline Partners LP 1.41M sh · $173.35M · Q2 2026
- ADAR1 Capital Management, LLC 960.86K sh · $117.78M · Q2 2026
- Hood River Capital Management LLC 882.74K sh · $108.21M · Q2 2026
- 683 Capital Management, LLC 290.00K sh · $35.55M · Q2 2026
- Eagle Health Investments LP 248.32K sh · $30.44M · Q2 2026
More on PERCEPTIVE ADVISORS LLC
FAQ
How long has PERCEPTIVE ADVISORS LLC held PTGX?
PERCEPTIVE ADVISORS LLC has disclosed PTGX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is PERCEPTIVE ADVISORS LLC's current position in PTGX?
As of Q2 2026, PERCEPTIVE ADVISORS LLC holds 981.88K shares of PTGX (PROTAGONIST THERAPEUTICS INC), valued at $120.36M, representing 1.91% of its reported portfolio and ranking #16.
Has PERCEPTIVE ADVISORS LLC been buying or selling PTGX?
In the latest 13F filing (Q2 2026), PERCEPTIVE ADVISORS LLC reduced its position in PTGX. The position peaked in Q1 2026 at 1.23M shares.
Which other funds hold PTGX?
Other major institutional holders of PTGX include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., RTW INVESTMENTS, LP, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.